![]() |
|
|
Vol. 288, Issue 2, 561-567, February 1999
Department of Pharmacology, Stritch School of Medicine, Loyola
University of Chicago, Maywood, Illinois
Long-term exposure to fluoxetine produces a desensitization of
hypothalamic postsynaptic 5-hydroxytryptamine (5-HT)1A
receptors, indicated by a substantial inhibition of the
5-HT1A receptor-mediated stimulation of oxytocin and
adrenocorticotropic hormone (ACTH) secretion. The present study
investigated the time course and mechanism of this desensitization
after discontinuation of fluoxetine administration. Male rats were
injected with saline or fluoxetine (10 mg/kg/day, i.p.) for 14 days and
were challenged with a 5-HT1A agonist,
[8-hydroxy-2-(dipropylamino)tetralin (8-OH-DPAT) 50 µg/kg, s.c.] 2, 4, 7, 14, 28, or 60 days post-treatment. In control animals, 8-OH-DPAT
significantly increased (approximately 15-fold) plasma levels of
oxytocin and ACTH. At 2 days post-treatment, oxytocin and ACTH
responses to 8-OH-DPAT were reduced by 74% and 68%,
respectively. During further withdrawal from fluoxetine, there
was a gradual increase in the oxytocin response toward control levels.
However, even 60 days after discontinuation of fluoxetine, the oxytocin response was still significantly reduced by 26% compared with controls. In contrast, the suppressed ACTH response to 8-OH-DPAT (a
less-sensitive indicator of desensitization) gradually returned to
control levels by day 14 of withdrawal from fluoxetine. Interestingly, the sustained reductions in the hormone responses occurred in the
absence of reductions in Gz or Gi protein
levels in the hypothalamus. Furthermore, this desensitization was
sustained in the absence of detectable levels of fluoxetine and
norfluoxetine in plasma and brain tissue. These findings suggest that
the sustained desensitization of hypothalamic 5-HT1A
receptor systems, observed during fluoxetine withdrawal, may be due to
altered interactions among the protein components of the
5-HT1A receptor system, rather than their absolute levels.